VNDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Vanda Pharmaceuticals Inc (VNDA) is not a strong buy for a beginner investor with a long-term strategy at this moment. The technical indicators suggest a bearish trend, insiders are heavily selling, and there are no significant positive catalysts or recent news to support a strong upward move. While options data shows a bullish sentiment with a low Put-Call ratio, the lack of financial performance data and negative technical trends make it prudent to hold off on investing in this stock for now.
The technical indicators for VNDA are bearish. The MACD histogram is negative and expanding downward, the RSI is neutral at 38.511, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 5.689 and resistance at 6.208.
NULL. There is no recent news or significant positive developments for VNDA.
Insiders are selling heavily, with a 972.59% increase in selling activity over the last month. Technical indicators are bearish, and there is no recent news or financial data to support a positive outlook.
No financial data available for the latest quarter, making it difficult to assess the company's growth trends or financial health.
H.C. Wainwright recently lowered the price target from $24 to $21 while maintaining a Buy rating. However, the reduction in price target is due to higher expected operating expenses, which is a negative factor for the stock.
